Beam Therapeutics Inc. (BEAM) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $14.95M | +67.1% |
| 2024 | $8.95M | -73.5% |
| 2023 | $33.73M | -31.1% |
| 2022 | $48.95M | +4.6% |
| 2021 | $46.81M | +186.2% |
| 2020 | $16.36M | +30.7% |
| 2019 | $12.52M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $14.95M | +67.1% |
| 2024 | $8.95M | -73.5% |
| 2023 | $33.73M | -31.1% |
| 2022 | $48.95M | +4.6% |
| 2021 | $46.81M | +186.2% |
| 2020 | $16.36M | +30.7% |
| 2019 | $12.52M | — |